Thalidomide-NH-amido-PEG1-C2-NH2 hydrochloride 13176 Valrubicin competes with the tumor

Valrubicin competes with the tumor promoter for the PKC binding site and prevents the latter from both interacting with the phospholipid and binding to PKC

Piperlongumine inhibits angiotensin II-induced extracellular matrix expression in cardiac fibroblasts

Anti-inflammatory effects of tretinoin (all-trans-retinoic acid) 0

InChiKey: WPDOZYZAJKUVRZ-DPACUSKXSA-N

3)17(14)8-22-17/h6

Thalidomide-NH-amido-PEG1-C2-NH2 hydrochloride 13176 Valrubicin competes with the tumorThalidomide NH amido PEG1 C2 NH2 hydrochloride is a synthesized E3 ligase ligand linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker used in PROTAC technology. Product information Molecular Weight: 453. 88 Formula: C19H24ClN5O6 Chemical Name: N [2 (2 aminoethoxy)ethyl] 2 {[2 (2,6 dioxopiperidin 3 yl) 1,3 dioxo 2,3 dihydro 1H isoindol 4 yl]amino}acetamide; chlorohydrogen Smiles: Cl.